These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 29459637)

  • 41. Effect of chronic IL-6 infusion on acute pressor responses to vasoconstrictors in mice.
    Boesen EI; Pollock DM
    Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1745-9. PubMed ID: 17557918
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic deletion of AT1a receptors attenuates intracellular accumulation of ANG II in the kidney of AT1a receptor-deficient mice.
    Li XC; Navar LG; Shao Y; Zhuo JL
    Am J Physiol Renal Physiol; 2007 Aug; 293(2):F586-93. PubMed ID: 17537986
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Angiotensin II-Induced Hypertension Is Attenuated by Reduction of Sympathetic Output in NO-Sensitive Guanylyl Cyclase 1 Knockout Mice.
    Broekmans K; Stegbauer J; Potthoff SA; Russwurm M; Koesling D; Mergia E
    J Pharmacol Exp Ther; 2016 Jan; 356(1):191-9. PubMed ID: 26559126
    [TBL] [Abstract][Full Text] [Related]  

  • 44. P-Selectin glycoprotein ligand 1 (PSGL-1) is a physiological ligand for E-selectin in mediating T helper 1 lymphocyte migration.
    Hirata T; Merrill-Skoloff G; Aab M; Yang J; Furie BC; Furie B
    J Exp Med; 2000 Dec; 192(11):1669-76. PubMed ID: 11104809
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nitric oxide synthase inhibition accelerates the pressor response to low-dose angiotensin II, exacerbates target organ damage, and induces renin escape.
    Hu L; Sealey JE; Chen R; Zhou Y; Merali C; Shi Y; Laragh JH; Catanzaro DF
    Am J Hypertens; 2004 May; 17(5 Pt 1):395-403. PubMed ID: 15110897
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute and chronic angiotensin hypertension: neural and nonneural components, time course, and dose dependency.
    Li Q; Dale WE; Hasser EM; Blaine EH
    Am J Physiol; 1996 Jul; 271(1 Pt 2):R200-7. PubMed ID: 8760221
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II.
    Qi Z; Hao CM; Langenbach RI; Breyer RM; Redha R; Morrow JD; Breyer MD
    J Clin Invest; 2002 Jul; 110(1):61-9. PubMed ID: 12093889
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulator of G protein signalling 2 ameliorates angiotensin II-induced hypertension in mice.
    Hercule HC; Tank J; Plehm R; Wellner M; da Costa Goncalves AC; Gollasch M; Diedrich A; Jordan J; Luft FC; Gross V
    Exp Physiol; 2007 Nov; 92(6):1014-22. PubMed ID: 17644703
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential phenotypes of tissue-infiltrating T cells during angiotensin II-induced hypertension in mice.
    Wei Z; Spizzo I; Diep H; Drummond GR; Widdop RE; Vinh A
    PLoS One; 2014; 9(12):e114895. PubMed ID: 25501574
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Autopotentiation of pressor responses by subpressor angiotensin II in rats.
    Abraham G; Simon G
    Am J Hypertens; 1994 Mar; 7(3):269-75. PubMed ID: 8003279
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronic p38 mitogen-activated protein kinase inhibition improves vascular function and remodeling in angiotensin II-dependent hypertension.
    Potthoff SA; Stamer S; Grave K; Königshausen E; Sivritas SH; Thieme M; Mori Y; Woznowski M; Rump LC; Stegbauer J
    J Renin Angiotensin Aldosterone Syst; 2016 Jul; 17(3):. PubMed ID: 27407119
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Delayed recovery of hypertension after single dose losartan in angiotensin II-infused conscious rats.
    Hu L; Catanzaro DF; Laragh JH; Sealey JE
    J Hypertens; 1999 Oct; 17(10):1443-50. PubMed ID: 10526905
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects.
    Masaki H; Kurihara T; Yamaki A; Inomata N; Nozawa Y; Mori Y; Murasawa S; Kizima K; Maruyama K; Horiuchi M; Dzau VJ; Takahashi H; Iwasaka T; Inada M; Matsubara H
    J Clin Invest; 1998 Feb; 101(3):527-35. PubMed ID: 9449684
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Deficiency of Complement C3a and C5a Receptors Prevents Angiotensin II-Induced Hypertension via Regulatory T Cells.
    Chen XH; Ruan CC; Ge Q; Ma Y; Xu JZ; Zhang ZB; Lin JR; Chen DR; Zhu DL; Gao PJ
    Circ Res; 2018 Mar; 122(7):970-983. PubMed ID: 29437833
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Attenuated responses to angiotensin II in follitropin receptor knockout mice, a model of menopause-associated hypertension.
    Javeshghani D; Touyz RM; Sairam MR; Virdis A; Neves MF; Schiffrin EL
    Hypertension; 2003 Oct; 42(4):761-7. PubMed ID: 12885794
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Peroxisome Proliferator Activated Receptor-α Agonist Slows the Progression of Hypertension, Attenuates Plasma Interleukin-6 Levels and Renal Inflammatory Markers in Angiotensin II Infused Mice.
    Wilson JL; Duan R; El-Marakby A; Alhashim A; Lee DL
    PPAR Res; 2012; 2012():645969. PubMed ID: 22848208
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The development of salt-sensitive hypertension regulated by PSGL-1 gene in mice.
    Yang Y; Liu X; Liu Y; Fu H; Gao Y; Liu X; Jiang X
    Cell Biosci; 2018; 8():20. PubMed ID: 29541444
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Blood pressure test value in arterial hypertension].
    TAQUINI AC
    Cuore Circ; 1947; 31(3-4):56. PubMed ID: 20340674
    [No Abstract]   [Full Text] [Related]  

  • 59. Correction: Inflammatory Molecule,
    Mol Cancer Res; 2020 Jun; 18(6):938. PubMed ID: 32487678
    [No Abstract]   [Full Text] [Related]  

  • 60. Expression of Concern: Inflammatory Molecule,
    Mol Cancer Res; 2020 Jun; 18(6):939. PubMed ID: 32487679
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.